Pharmabiz

KPRDO sounds alarm over unauthorised medicine substitution & misleading discount schemes

KPRDO sounds alarm over unauthorised medicine substitution & misleading discount schemes: Nandita Vijayasimha, Bengaluru The ...
Pharmabiz

CDSCO formalises algorithm change protocol to streamline AI/ML software updates

CDSCO formalises algorithm change protocol to streamline AI/ML software updates: Peethaambaran Kunnathoor, Chennai In a ...
Pharmabiz

CDSCO issues clarification on applications related to compounding of offences

CDSCO issues clarification on applications related to compounding of offences: Gireesh Babu, New Delhi Friday, July 24, 2026, ...
Pharmabiz

JNCH revises export procedures for bringing major relief to merchant exporters

JNCH revises export procedures for bringing major relief to merchant exporters: Shardul Nautiyal, Mumbai In a significant move aimed at stre ...
Pharmabiz

Indian pharma concerned over US President’s proposed tariffs on generics

Indian pharma concerned over US President’s proposed tariffs on generics: Nandita Vijayasimha, Bengaluru Indian pharmaceutical industry ha ...
Pharmabiz

Karnataka FDA and US FDA hold strategic consultation to strengthen food and drug regulation

Karnataka FDA and US FDA hold strategic consultation to strengthen food and drug regulation: Our Bureau, Bengaluru Thursday, ...
Pharmabiz

LSSSDC and TN IDMA to host NAPS awareness workshop for pharma sector in Chennai tomorrow, July 24

LSSSDC and TN IDMA to host NAPS awareness workshop for pharma sector in Chennai tomorrow, July 24: Our Bureau, Chennai Thursday, July 23, 2026, 14:45 Hrs [IST] The Life Sciences S ...
Pharmabiz

UK MHRA approves Chiesi’s Clenil Modulite, a pressurised metered-dose inhalers containing a next-generation, low GWP propellant

UK MHRA approves Chiesi’s Clenil Modulite, a pressurised metered-dose inhalers containing a next-generation, low GWP propellant: Manchester, UK Thursday, July 23, 2026, 15:00 Hr ...
Pharmabiz

Pharma and healthcare deals resilient at US$ 13.9 bn in Q2 2026, driven by strategic outbound acquisitions: Grant Thornton Bharat

Pharma and healthcare deals resilient at US$ 13.9 bn in Q2 2026, driven by strategic outbound acquisitions: Grant Thornton Bharat: Our Bureau, Bengaluru Thursday, July 23, 2026, 1 ...
Pharmabiz

Healx begins patient dosing in phase 1/2 trial to evaluate the effect of HLX-4310 on metastatic recurrence and progression in sarcomas with a focus on osteosarcoma

Healx begins patient dosing in phase 1/2 trial to evaluate the effect of HLX-4310 on metastatic recurrence and progression in sarcomas with a focus on osteosarcoma: Cambridge, UK ...
Pharmabiz

US FDA approves Rapid Medical’s DRIVEWIRE 35,a steerable 0.035-inch guidewire designed to help physicians reach the treatment site quickly

US FDA approves Rapid Medical’s DRIVEWIRE 35,a steerable 0.035-inch guidewire designed to help physicians reach the treatment site quickly: Seattle Thursday, July 23, 2026, 12:0 ...
Pharmabiz

JCR Pharma’s Izcargo, a blood-brain barrier-penetrating ERT for Hunter syndrome receives UAE marketing authorization

JCR Pharma’s Izcargo, a blood-brain barrier-penetrating ERT for Hunter syndrome receives UAE marketing authorization: Hyogo, Japan Thursday, July 23, 2026, 14:00 Hrs [IST] JCR P ...